Ahead of the Curve: Early Interventions for Delaying Type 1 Diabetes
Javier Morales, MD, FACP, FACE; David Robertson, MD; Andrea Stallings, PA, and Shira Eytan, MD, FACE, examine the comprehensive burden of Type 1 diabetes, from screening guidelines and disease staging to the critical importance of early intervention, emphasizing how delayed treatment in Stage 2 can lead to severe complications and diminished therapeutic opportunities.
EP. 1: Assessing the Burden of Type 1 Diabetes
December 19th 2024Panelists discuss how Type 1 diabetes imposes significant physical, emotional, and financial burdens on patients through the lifelong need for insulin therapy, blood glucose monitoring, lifestyle modifications, and management of potential complications.
